LIGAND PHARMACEUTICALS (LGND)
US53220K5048 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to LGND. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 126.95. This target is 11.55% above the current price.
LGND was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about LGND.
In the previous month the buy percentage consensus was at a similar level.
LGND was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-23 | Benchmark | Reiterate | Buy -> Buy |
| 2024-12-16 | Barclays | Maintains | Overweight -> Overweight |
| 2024-12-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-08 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-28 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-03 | Oppenheimer | Initiate | Outperform |
| 2024-08-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-12 | Benchmark | Maintains | Buy -> Buy |
| 2024-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-30 | RBC Capital | Initiate | Outperform |
| 2024-07-09 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-07-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-28 | Benchmark | Reiterate | Buy -> Buy |
| 2024-06-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-12 | Benchmark | Reiterate | Buy -> Buy |
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-13 | Benchmark | Reiterate | Buy -> Buy |
| 2023-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-23 | Benchmark | Reiterate | Buy -> Buy |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-25 | Barclays | Maintains | Overweight -> Overweight |